EAPCI Column

DOI:

EAPCI Focus on the EAPCI Scientific Documents and Initiatives Committee

An interview with the Chair Giulio Stefanini

Figure 1

Figure 1.

What is the role of the committee?

Any proposal for scientific documents received by the EAPCI must be submitted to the Scientific Documents and Initiatives Committee (SDIC) for approval prior to their development. Together with my Co-Chair Nieves Gonzalo and committee members, the SDIC reviews all document proposals and makes approval or rejection recommendations. These recommendations are then reviewed and confirmed by the EAPCI Executive Committee. The responsibilities of the committee include the screening and validation of solicited and unsolicited documentation proposals as well as the identification of topics suitable for EAPCI scientific documents. Once the topic has been selected and approved, the committee is responsible for the administrative supervision and coordination of Writing Groups, coordination of the declarations of interest process for appointed authors as well as coordination of the review process.

How do EAPCI scientific documents benefit the community?

The key benefit of EAPCI scientific documents is to provide guidance for clinical management on topics not covered, or not covered in sufficient detail, in the existing or upcoming ESC Clinical Practice Guidelines. Whilst their topics and scope should not overlap with those of guidelines, scientific documents may complement them by providing more in-depth information in specific areas that cannot be expanded upon in guidelines. Our scientific documents evaluate scientific evidence, explore expert consensus in a structured way and, typically, include very practical advice for daily management of the topics discussed.

How are topics chosen and how can EAPCI members contribute?

Any EAPCI member may submit a proposal for a scientific document; any proposal received is subject to the robust and transparent review process of the SDIC followed by the EAPCI Executive Committee. Furthermore, one of the roles of the SDIC is to identify areas of unmet need and propose these topics to the EAPCI Executive Committee for consideration.

What are the upcoming topics?

  • Percutaneous coronary intervention in patients with cancer
  • Follow-up strategies in patients after transcatheter aortic valve replacement
  • Day-clinic care for percutaneous cardiovascular interventions
  • Sex-related considerations in mitral and tricuspid valve interventions

News

  • Attending ESC Congress 2023 in Amsterdam from August 25th-28th? Come to the ESC Plaza and find out more about EAPCI.
  • Not yet an EAPCI member? Join online https://www.escardio.org/EAPCI
Volume 19 Number 5
Aug 7, 2023
Volume 19 Number 5
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00648 Jul 20, 2026
When less is no longer more: very early aspirin discontinuation after ACS
Piccolo R and Vitale A
free

Editorial

10.4244/EIJ-E-26-00010 Jul 20, 2026
Aspirin withdrawal after primary PCI for STEMI: timing matters
Paradies V and Mancini G
free

Editorial

10.4244/EIJ-D-26-00715 Jul 20, 2026
Endotype-guided management of ANOCA: are we ready?
Montone R
free

Original Research

10.4244/EIJ-D-26-00148 Jul 20, 2026
Endotype-guided medical therapy and symptom response in ANOCA
Farina J et al

Research Correspondence

10.4244/EIJ-D-25-01215 Jul 20, 2026
Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention
Crooijmans C et al

Flashlight

10.4244/EIJ-D-25-00731 Jul 20, 2026
Collapse of a new-generation magnesium scaffold
Bastante T et al
Trending articles
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
48.5

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
45.65

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.9

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
21.9

Research Correspondence

10.4244/EIJ-D-26-00271 May 20, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al
21.9

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved